pidilizumab - CISMeF

Preferred Label : pidilizumab;

MeSH note : an anti-programmed death 1 (PD-1) antibody; in phase II clinical trials (2013);

MeSH hyponym : CT 011;

Is substance : O;

UNII : B932PAQ1BQ;

Details

Origin ID

C585832;

UMLS CUI

C2346821;

Currated CISMeF NLP mapping
- Pidilizumab [NCIt concept]
MeSH indexing information
- antineoplastic agents [MeSH Descriptor]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Record concept(s)
- CT-011 [MeSH concept]
- pidilizumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Pidilizumab [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients